Our Patient Commitment

As the end-user of our products and services, we are dedicated to improving the quality of life of our patients suffering from a variety of blood clotting disorders, immune deficiencies, and other illnesses.


Learn more 

The Octapharma mission "for the safe and optimal use of human proteins" conveys the company's focus and dedication to a specialized portfolio of products.

 

 

Explore our products 

News & Press Releases

01.03.2017
Octapharma Group publishes 2016 annual results reporting revenue of €1.6 billion and operating income of €383 million

Lachen, Switzerland, March 1st, 2017: The Octapharma Group can report a record-breaking result with ...

22.12.2016
Octapharma donates Nuwiq® to the WFH Humanitarian Aid Program to provide patients with haemophilia A in developing countries access to therapy

Lachen, Switzerland, December 22nd, 2016: Octapharma is proud to announce that the company has made ...